Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Net Income (2016 - 2025)

iBio (IBIO) has disclosed Net Income for 16 consecutive years, with -$9.0 million as the latest value for Q4 2025.

  • Quarterly Net Income fell 106.07% to -$9.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$24.7 million through Dec 2025, down 84.3% year-over-year, with the annual reading at -$18.4 million for FY2025, 94.18% down from the prior year.
  • Net Income for Q4 2025 was -$9.0 million at iBio, down from -$5.7 million in the prior quarter.
  • The five-year high for Net Income was -$537000.0 in Q1 2024, with the low at -$23.0 million in Q4 2022.
  • Average Net Income over 5 years is -$5.8 million, with a median of -$4.8 million recorded in 2021.
  • The sharpest move saw Net Income soared 93.66% in 2023, then crashed 805.21% in 2025.
  • Over 5 years, Net Income stood at -$4.7 million in 2021, then crashed by 386.15% to -$23.0 million in 2022, then soared by 83.81% to -$3.7 million in 2023, then fell by 17.22% to -$4.4 million in 2024, then crashed by 106.07% to -$9.0 million in 2025.
  • According to Business Quant data, Net Income over the past three periods came in at -$9.0 million, -$5.7 million, and -$5.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.